NCT02992106

Brief Summary

The rising worldwide prevalence of obesity and its subsequently rising incidence of concommitant diseases as diabetes and cardiovascular events impose a defiant obstacle for the health care and associated health care costs of future generations. Obese pregnant women are a growing population of interest because their offspring is at risk for childhood obesity, an adverse metabolic and inflammatory profile and possible endothelial dysfunction. However, strong evidence is still lacking regarding the hypotheses on the early origin of these long-term health consequences. Consequently there is no comprehensive data available on the contribution of changing maternal weight through lifestyle interventions or bariatric surgery and an eventual adverse metabolic and endothelial programming of the offspring. The investigators of this study want to provide additional data on the body composition, metabolic and inflammatory state as well as endothelial function of children of obese pregnant women women and compare the outcome with children born from normal weight women. Furthermore, the investigators of this study will stratify the obese pregnant women into 3 groups: women who did not underwent an intervention, women who underwent a weight changing intervention during pregnancy e.g. diet or lifestyle intervention and women who underwent bariatric surgery before pregnancy. The overall aim of the study is to prove that in all the diverse groups of participating children, except the control group, there will be a certain grade of endothelial dysfunction, even if there was a normalization of weight, insulin sensitivity and inflammation before conception or delivery in the mother.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
143

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 5, 2016

Completed
9 days until next milestone

First Posted

Study publicly available on registry

December 14, 2016

Completed
5 months until next milestone

Study Start

First participant enrolled

May 10, 2017

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 18, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 18, 2019

Completed
Last Updated

August 7, 2019

Status Verified

August 1, 2019

Enrollment Period

1.9 years

First QC Date

December 5, 2016

Last Update Submit

August 6, 2019

Conditions

Keywords

Maternal ObesityEndothelial DysfunctionChildhood Obesity

Outcome Measures

Primary Outcomes (3)

  • Reactive Hyperemia Index (EndoPAT)

    Reactive Hyperemia Index is one of the outcome parameters of the EndoPAT assessment of endothelial cell function

    Through study completion, average of 18 months

  • Albumin to creatinin ratio in urine

    Albumin to creatinin ratio is considered an early marker of endothelial cell dysfunction

    Through study completion, average of 18 months

  • Peak response after occlusion (EndoPAT)

    Determination of the peak response using 30s average of amplitude intervals./ In children considered as an important measurement regarding assessment of the endothelial cell function

    Through study completion, average of 18 months

Secondary Outcomes (5)

  • BMI (kg/m²)

    Through study completion, average of 18 months

  • Body fat percentage

    Through study completion, average of 18 months

  • Insulin resistance

    Through study completion, average of 18 months

  • Inflammatory state of the child (hs-CRP and IL-6)

    Through study completion, average of 18 months

  • Lipid state in blood

    Through study completion, average of 18 months

Study Arms (4)

Normal weight during pregnancy

OTHER

Offspring of 156 women with a normal weight during their pregnancy recruited by Bogaerts et al, in 3 belgian hospitals. Results of maternal data published in 2013. Now the children will be recruited. This group wil function as a control group. All participating children will undergo the same examinations: * Parental questionnaires * Blood sample * Urine sample * Anthropometric measurements * Abdominal ultrasound (fat mass) * EndoPAT

Other: Parental questionnairesOther: Blood sampleOther: Urine sampleOther: Anthropometric measurementsOther: UltrasoundOther: EndoPATOther: Faces Pain Scale

Obese mothers without intervention

OTHER

This subgroup will be compiled of the offspring of women recruited in two different studies. First of all there is the offspring of 65 women from the cohort that was recruited by Guelinckx et al, data published in 2010. This population was recruited in the University hospital of Leuven as control group for women receiving lifestyle interventions during pregnancy. Secondly there are children of 63 women from the cohort of Bogaerts et al of 2013 that had a BMI \> 29 kg/m² during their singleton pregnancy. All participating children will undergo the same examinations: * Parental questionnaires * Blood sample * Urine sample * Anthropometric measurements * Abdominal ultrasound (fat mass) * EndoPAT

Other: Parental questionnairesOther: Blood sampleOther: Urine sampleOther: Anthropometric measurementsOther: UltrasoundOther: EndoPATOther: Faces Pain Scale

Obese mothers & lifestyle intervention

OTHER

This one will also be a composition of study subjects of two different study cohorts. Firstly there are children of about 100 Belgian women that were included in the DALI cohort, a European randomized controlled trial. All of them underwent a lifestyle intervention during pregnancy, concerning diet and/ or exercise. Secondly there is the offspring of the other subgroup of the cohort recruited by Guelinckx et al. 130 women were divided into 2 groups which underwent lifestyle interventions during pregnancy. All participating children will undergo the same examinations: * Parental questionnaires * Blood sample * Urine sample * Anthropometric measurements * Abdominal ultrasound (fat mass) * EndoPAT

Other: Parental questionnairesOther: Blood sampleOther: Urine sampleOther: Anthropometric measurementsOther: UltrasoundOther: EndoPATOther: Faces Pain Scale

History of bariatric surgery

OTHER

The PABAS cohort (Pregnancy After Bariatric Surgery) provides children of 49 women who underwent bariatric surgery before their singleton pregnancy. The women were included in five Flemish hospitals before 15 weeks of pregnancy. Furthermore we will recruit the offspring of 200 women that are recruited in the ongoing AURORA cohort (bAriatric sUrgery Registration in women Of Reproductive Age). Women in this cohort are recruited from the start of their process undergoing bariatric surgery and are followed until after their pregnancy. All participating children will undergo the same examinations: * Parental questionnaires * Blood sample * Urine sample * Anthropometric measurements * Abdominal ultrasound (fat mass) * EndoPAT

Other: Parental questionnairesOther: Blood sampleOther: Urine sampleOther: Anthropometric measurementsOther: UltrasoundOther: EndoPATOther: Faces Pain Scale

Interventions

We will provide parents with questionnaires depending on the age of their children: * Children aged 0-6 years old: 1. Questionnaire on socio-demographic characteristics 2. Dutch Eating Behaviour Questionnaire 3. Food Frequency Questionnaire 4. Ages and Stages Questionnaire 5. Strengths and Difficulties Questionnaire 6. Questionnaire on developmental milestones 7. Questionnaire on behaviour * Children older than 6 years: 1. Questionnaire on socio-demographic characteristics 2. Dutch Eating Behaviour Questionnaire 3. Food Frequency Questionnaire 4. Pediatric Quality of Life Questionnaire 5. Children's Behaviour Questionnaire in Dutch 6. Questionnaire on developmental milestones 7. Developmental Coordination Disorder Questionnaire 8. Strengths and Difficulties Questionnaire

History of bariatric surgeryNormal weight during pregnancyObese mothers & lifestyle interventionObese mothers without intervention

We will determine the following biochemical parameters: glucose, insulin, total cholesterol, LDL, HDL, triglycerides, uric acid, IGF-1, adiponectin, leptin, hs-CRP, IL-6, TNF-α and ICAM-1.

History of bariatric surgeryNormal weight during pregnancyObese mothers & lifestyle interventionObese mothers without intervention

We will take a urine sample to evaluate the albumin to creatinin ratio.

History of bariatric surgeryNormal weight during pregnancyObese mothers & lifestyle interventionObese mothers without intervention

We will measure weight, Height, hip, waist and neck circumference, blood pressure, 4-site skinfold measurements and BIA.

History of bariatric surgeryNormal weight during pregnancyObese mothers & lifestyle interventionObese mothers without intervention

We will do an abdominal ultrasound to measure the abdominal fat accumulation

History of bariatric surgeryNormal weight during pregnancyObese mothers & lifestyle interventionObese mothers without intervention
EndoPATOTHER

We will use the EndoPAT device to measure endothelial function, which is a non-invasive and innovative technique (peripheral pulse wave amplitude measurement).

History of bariatric surgeryNormal weight during pregnancyObese mothers & lifestyle interventionObese mothers without intervention

After performing the measurements with the EndoPAT device, Harpender kalliper and ultrasound, the children will be asked to fill out a Faces Pain Scale, validated for children aged 4-16 years old and obtained for use from the International Association for the Study of Pain

History of bariatric surgeryNormal weight during pregnancyObese mothers & lifestyle interventionObese mothers without intervention

Eligibility Criteria

Age6 Months - 11 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Children of women who previously participated in different cohort studies conducted in Flanders concerning maternal obesity are included after contacting the mothers again. During the initial clinical trials the mothers were informed of possible follow-up studies on their offspring.

You may not qualify if:

  • For the peripheral pulse wave amplitude measurement we exclude children on growth hormone therapy.
  • We postpone the examination for 2 weeks if there is an ongoing infection.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital of Brussels

Brussels, 1090, Belgium

Location

Related Publications (1)

  • Van De Maele K, Gies I, Devlieger R. Effect of bariatric surgery before pregnancy on the vascular function in the offspring: protocol of a cross-sectional follow-up study. BMJ Paediatr Open. 2019 Jan 31;3(1):e000405. doi: 10.1136/bmjpo-2018-000405. eCollection 2019.

MeSH Terms

Conditions

Pediatric ObesityPregnancy in Obesity

Interventions

Blood Specimen CollectionHigh-Energy Shock Waves

Condition Hierarchy (Ancestors)

ObesityOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative TechniquesUltrasonic WavesSoundRadiation, NonionizingRadiationPhysical Phenomena

Study Officials

  • Roland Devlieger, Professor

    Universitaire Ziekenhuizen KU Leuven

    STUDY DIRECTOR
  • Inge Gies, Professor

    Universitair Ziekenhuis Brussel

    PRINCIPAL INVESTIGATOR
  • Karolien Van De Maele, M.D.

    Universitair Ziekenhuis Brussel

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Pediatric Endocrinologist

Study Record Dates

First Submitted

December 5, 2016

First Posted

December 14, 2016

Study Start

May 10, 2017

Primary Completion

March 18, 2019

Study Completion

March 18, 2019

Last Updated

August 7, 2019

Record last verified: 2019-08

Data Sharing

IPD Sharing
Will not share

Locations